Fusion Pharmaceuticals Inc. Operating Lease Right-of-Use Assets
Fusion Pharmaceuticals Inc. had Operating Lease Right-of-Use Assets of $17.86 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-05-07
- 2024-03-31: Operating Lease, Right-of-Use Asset $17.86M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $18.59M.
- 2023-09-30: Operating Lease, Right-of-Use Asset $19.52M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $17.63M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2024-03-31 | $17.86M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $18.59M 10-Q · filed 2024-05-07 | |
| 2023-09-30 | $19.52M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $17.63M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $17.84M 10-Q · filed 2023-05-11 | |
| 2023-02-28 | $2.20M 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $5.68M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $5.97M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $6.26M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.54M 10-Q · filed 2022-05-10 | |
| 2022-01-12 | $300.00K 10-Q · filed 2024-05-07 | |
| 2021-12-31 | $6.49M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $6.95M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $7.22M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $900.00K 10-Q · filed 2024-05-07 | $7.50M 10-Q · filed 2021-05-11 |
| 2021-03-16 | $900.00K 10-K · filed 2024-03-20 |